DUBLIN–(BUSINESS WIRE)–The “Hepatitis B – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.
The pipeline guide provides comprehensive information on the therapeutics under development for Hepatitis B, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Hepatitis B.
- The pipeline guide reviews pipeline therapeutics for Hepatitis B by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Hepatitis B therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Hepatitis B (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects. (Read more…)
-
The pipeline guide reviews latest news related to pipeline therapeutics for Hepatitis B
Key Topics Covered:
Introduction
- Hepatitis B- Overview
- Hepatitis B- Therapeutics Development
- Hepatitis B- Therapeutics Assessment
- Hepatitis B- Companies Involved in Therapeutics Development
- Hepatitis B- Drug Profiles
- Hepatitis B- Dormant Projects
- Hepatitis B- Discontinued Products
- Hepatitis B- Product Development Milestones
Companies Mentioned
- Abhelix LLC
- Ai-biopharma SAS
- AiCuris GmbH & Co KG
- AIMM Therapeutics BV
- Akshaya Bio Inc
- Aligos Therapeutics Inc
- AlloVir Inc
- AlphaMab Co Ltd
- Alphamab Oncology
- Altimmune Inc
- Antios Therapeutics Inc
- Apros Therapeutics Inc
- Arbutus Biopharma Corp
- Arcturus Therapeutics Ltd
- Ark Biosciences Inc
- Ascentage Pharma Group International
- Ascletis Pharma Inc
- Assembly Biosciences Inc
- Atea Pharmaceuticals Inc
- Aucta Pharmaceuticals LLC
- Avalia Immunotherapies Ltd
- Beijing Advaccine Biotechnology Company Ltd
- Beijing Kawin Technology Share-Holding Co Ltd
- Beijing Minhai Biotechnology Co Ltd
- Benitec Biopharma Inc
- Biological E Ltd
- Biomics Biopharma Ltd
- BioNet-Asia Co Ltd
- Biotron Ltd
- Bolder Biotechnology Inc
- Bonac Corp
- Brandenburg Antiinfektiva GmbH
- Brickell Biotech Inc
- BrightGene Bio-Medical Technology Co Ltd
- Bukwang Pharmaceutical Co Ltd
- Cadila Healthcare Ltd
- CaroGen Corp
- Casterbridge Pharmaceuticals Inc
- Chengdu Hyperway Pharmaceuticals
- Chia Tai Tianqing Pharmaceutical Group Co Ltd
- Chong Kun Dang Pharmaceutical Corp
- Chongqing Zhifei Biological Products Co Ltd
- Cinkate Corp
- CN Bio Innovations Ltd
- Cocrystal Pharma Inc
- Collaborations Pharmaceuticals Inc
- Cytocom Inc
- CyTuVax BV
- Decoy Biosystems Inc
- DelSiTech Ltd
- Dicerna Pharmaceuticals Inc
- Door Pharmaceuticals LLC
- Dynavax Technologies Corp
- Elixiron Immunotherapeutics Inc
- Enanta Pharmaceuticals Inc
- Enochian Biosciences Inc
- Enyo Pharma SA
- Etna Biotech Srl
- Excision BioTherapeutics Inc
- F. Hoffmann-La Roche Ltd
- Finch Therapeutics Group
- FortuneRock (China) Ltd
- Fujian Cosunter Pharmaceutical Co Ltd
- GC Pharma
- GemVax & KAEL Co Ltd
- GeneCure LLC
- GeneScience Pharmaceuticals Co Ltd
- GeoVax Labs Inc
- Gilead Sciences Inc
- Ginkgo Tree Pharmaceutical (Suzhou) Co Ltd
- GlaxoSmithKline Plc
- Golden Biotechnology Corp
- Guangdong East Sunshine Pharmaceutical Co Ltd
- Guangxi Hebabiz Pharmaceutical Co Ltd
- Guangzhou Yipinhong Pharmaceutical Co Ltd
- HEC Pharm Co Ltd
- Hepion Pharmaceuticals Inc
- Huahui Anjian (Beijing) Biotechnology Co Ltd
- Humabs BioMed SA
- Huons Co Ltd
- ImmuneMed Inc
- Immunocore Ltd
- Immunotope Inc
- Innovent Biologics Inc
- Inovio Pharmaceuticals Inc
- Ionis Pharmaceuticals Inc
- ISA Pharmaceuticals BV
- ISR Immune System Regulation Holding AB
- Jiangsu Hansoh Pharmaceutical Group Co Ltd
- Jiangsu Hengrui Medicine Co Ltd
- Johnson & Johnson
- Jubilant Therapeutics Inc
- Kainos Medicine Inc
- KinoPharma Inc
- LG Chem Ltd
- Ligand Pharmaceuticals Inc
- Lion TCR Pte Ltd
- Max Biopharma Inc
- Microbiotix Inc
- MYR GmbH
- Novo Medi Sciences Pvt Ltd
- Nucorion Pharmaceuticals Inc
- Oncolys BioPharma Inc
- Palisades Therapeutics
- PharmaEssentia Corp
- Precision Biosciences Inc
- Profarma
- Profectus BioSciences Inc
- Protheragen Inc
- Qilu Pharmaceutical Co Ltd
- Regeneron Pharmaceuticals Inc
- Regulus Therapeutics Inc
- Replicor Inc
- Resonance Health Ltd
- Rodos BioTarget GmbH
- Romark Laboratories LC
- Samjin Pharm Co Ltd
- Sclnow Biotechnology Co Ltd
- Scynexis Inc
- SFA Therapeutics LLC
- Shanghai Henlius Biotech Inc
- Shanghai HEP Pharmaceutical Co Ltd
- Shanghai Zhimeng Biopharma Inc
- Shantha Biotechnics Pvt Ltd
- Shenzhen BinDeBio Ltd
- Sichuan Kelun Pharmaceutical Co Ltd
- Silverback Therapeutics Inc
- Sinovac Biotech Ltd
- SL VaxiGen Inc
- Staidson BioPharma Inc
- Suzhou Ribo Life Sciences Co Ltd
- TaiGen Biotechnology Co Ltd
- Takeda Pharmaceutical Co Ltd
- TCM Biotech International Corp
- TeneoBio Inc
- Tetranov International Inc
- Theravectys SA
- THEVAX Genetics Vaccine USA Inc
- Transgene SA
- UBI Pharma Inc
- Vaccitech Ltd
- Vaxart Inc
- Vaxine Pty Ltd
- VBI Vaccines Inc
- VenatoRx Pharmaceuticals Inc
- Vir Biotechnology Inc
- Viravaxx AG
- Viriom Inc
- Virion Therapeutics LLC
- Virocovax
- ViroStatics SRL
- VLP Biotech Inc
- Xi’an Xintong Pharmaceutical Research Co Ltd
- Yisheng Biopharma Co Ltd
- Zelluna Immunotherapy AS
- Zhejiang Bola Atu Pharmaceutical Technology Co Ltd
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/4n37hd
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900